Initial Investment



Clinical Decision AI

Optellum was founded to enable every lung disease patient to be diagnosed and treated at the earliest possible stage, improving outcomes for patients whilst reducing unnecessary interventions. Optellum redefines how early lung disease should be intercepted, enabling every clinician in every hospital to manage their patients in the optimal way. Optellum’s solution is based on machine learning applied to the world’s largest clinical dataset of CT scans.

IQ Capital first invested in Optellum at seed stage in 2019.